vs
GEO GROUP INC（GEO）与Medpace Holdings, Inc.（MEDP）财务数据对比。点击上方公司名可切换其他公司
Medpace Holdings, Inc.的季度营收约是GEO GROUP INC的1.0倍（$708.5M vs $708.4M），Medpace Holdings, Inc.净利率更高（19.1% vs 4.5%，领先14.6%），Medpace Holdings, Inc.同比增速更快（32.0% vs 16.6%），Medpace Holdings, Inc.自由现金流更多（$188.1M vs $-153.6M），过去两年Medpace Holdings, Inc.的营收复合增速更高（17.7% vs 8.1%）
GEO集团是一家总部位于美国佛罗里达州博卡拉顿的上市企业，核心业务为投资及运营私营监狱、心理健康相关机构，业务覆盖美国、澳大利亚、南非、英国等市场，运营设施包含移民拘留中心、低安保级别拘留中心、心理健康及 residential 治疗机构，同时也承接政府所有设施的委托管理服务。
Medpace Holdings, Inc.是总部位于美国俄亥俄州辛辛那提的全球性临床研究机构（CRO），现有员工约6000人。公司采用全服务运营模式，可提供全球中心实验室、影像核心实验室、生物分析实验室服务，且在总部临床研究园区内设有I期临床试验单元。
GEO vs MEDP — 直观对比
营收规模更大
MEDP
是对方的1.0倍
$708.4M
营收增速更快
MEDP
高出15.5%
16.6%
净利率更高
MEDP
高出14.6%
4.5%
自由现金流更多
MEDP
多$341.7M
$-153.6M
两年增速更快
MEDP
近两年复合增速
8.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $708.4M | $708.5M |
| 净利润 | $31.8M | $135.1M |
| 毛利率 | — | — |
| 营业利润率 | 11.8% | 21.6% |
| 净利率 | 4.5% | 19.1% |
| 营收同比 | 16.6% | 32.0% |
| 净利润同比 | 105.1% | 15.5% |
| 每股收益（稀释后） | $0.16 | $4.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GEOMEDP
| Q4 25 | $708.4M | $708.5M | ||
| Q3 25 | $682.3M | $659.9M | ||
| Q2 25 | $636.2M | $603.3M | ||
| Q1 25 | $604.6M | $558.6M | ||
| Q4 24 | $607.7M | $536.6M | ||
| Q3 24 | $603.1M | $533.3M | ||
| Q2 24 | $607.2M | $528.1M | ||
| Q1 24 | $605.7M | $511.0M |
净利润GEOMEDP
| Q4 25 | $31.8M | $135.1M | ||
| Q3 25 | $173.9M | $111.1M | ||
| Q2 25 | $29.1M | $90.3M | ||
| Q1 25 | $19.6M | $114.6M | ||
| Q4 24 | $15.5M | $117.0M | ||
| Q3 24 | $26.3M | $96.4M | ||
| Q2 24 | $-32.5M | $88.4M | ||
| Q1 24 | $22.7M | $102.6M |
营业利润率GEOMEDP
| Q4 25 | 11.8% | 21.6% | ||
| Q3 25 | 6.0% | 21.5% | ||
| Q2 25 | 11.3% | 20.9% | ||
| Q1 25 | 10.1% | 20.3% | ||
| Q4 24 | 11.2% | 23.4% | ||
| Q3 24 | 13.7% | 21.1% | ||
| Q2 24 | 13.2% | 19.9% | ||
| Q1 24 | 13.1% | 20.4% |
净利率GEOMEDP
| Q4 25 | 4.5% | 19.1% | ||
| Q3 25 | 25.5% | 16.8% | ||
| Q2 25 | 4.6% | 15.0% | ||
| Q1 25 | 3.2% | 20.5% | ||
| Q4 24 | 2.5% | 21.8% | ||
| Q3 24 | 4.4% | 18.1% | ||
| Q2 24 | -5.4% | 16.7% | ||
| Q1 24 | 3.7% | 20.1% |
每股收益（稀释后）GEOMEDP
| Q4 25 | $0.16 | $4.65 | ||
| Q3 25 | $1.24 | $3.86 | ||
| Q2 25 | $0.21 | $3.10 | ||
| Q1 25 | $0.21 | $3.67 | ||
| Q4 24 | $0.14 | $3.67 | ||
| Q3 24 | $0.19 | $3.01 | ||
| Q2 24 | $-0.25 | $2.75 | ||
| Q1 24 | $0.14 | $3.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.0M | $497.0M |
| 总债务越低越好 | $1.7B | — |
| 股东权益账面价值 | $1.5B | $459.1M |
| 总资产 | $3.8B | $2.0B |
| 负债/权益比越低杠杆越低 | 1.11× | — |
8季度趋势，按日历期对齐
现金及短期投资GEOMEDP
| Q4 25 | $69.0M | $497.0M | ||
| Q3 25 | $183.9M | $285.4M | ||
| Q2 25 | $67.9M | $46.3M | ||
| Q1 25 | $64.8M | $441.4M | ||
| Q4 24 | $76.9M | $669.4M | ||
| Q3 24 | $70.6M | $656.9M | ||
| Q2 24 | $46.3M | $510.9M | ||
| Q1 24 | $126.5M | $407.0M |
总债务GEOMEDP
| Q4 25 | $1.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GEOMEDP
| Q4 25 | $1.5B | $459.1M | ||
| Q3 25 | $1.5B | $293.6M | ||
| Q2 25 | $1.4B | $172.4M | ||
| Q1 25 | $1.3B | $593.6M | ||
| Q4 24 | $1.3B | $825.5M | ||
| Q3 24 | $1.3B | $881.4M | ||
| Q2 24 | $1.3B | $763.6M | ||
| Q1 24 | $1.3B | $671.5M |
总资产GEOMEDP
| Q4 25 | $3.8B | $2.0B | ||
| Q3 25 | $3.8B | $1.8B | ||
| Q2 25 | $3.7B | $1.6B | ||
| Q1 25 | $3.6B | $1.9B | ||
| Q4 24 | $3.6B | $2.1B | ||
| Q3 24 | $3.6B | $2.1B | ||
| Q2 24 | $3.6B | $1.9B | ||
| Q1 24 | $3.7B | $1.8B |
负债/权益比GEOMEDP
| Q4 25 | 1.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-117.3M | $192.7M |
| 自由现金流经营现金流 - 资本支出 | $-153.6M | $188.1M |
| 自由现金流率自由现金流/营收 | -21.7% | 26.6% |
| 资本支出强度资本支出/营收 | 5.1% | 0.6% |
| 现金转化率经营现金流/净利润 | -3.69× | 1.43× |
| 过去12个月自由现金流最近4个季度 | $-124.9M | $681.9M |
8季度趋势，按日历期对齐
经营现金流GEOMEDP
| Q4 25 | $-117.3M | $192.7M | ||
| Q3 25 | $79.6M | $246.2M | ||
| Q2 25 | $39.2M | $148.5M | ||
| Q1 25 | $71.2M | $125.8M | ||
| Q4 24 | $18.5M | $190.7M | ||
| Q3 24 | $109.3M | $149.1M | ||
| Q2 24 | $31.2M | $116.4M | ||
| Q1 24 | $83.3M | $152.7M |
自由现金流GEOMEDP
| Q4 25 | $-153.6M | $188.1M | ||
| Q3 25 | $-14.1M | $235.5M | ||
| Q2 25 | $2.4M | $142.4M | ||
| Q1 25 | $40.5M | $115.8M | ||
| Q4 24 | $-2.3M | $183.0M | ||
| Q3 24 | $90.5M | $138.5M | ||
| Q2 24 | $6.8M | $103.5M | ||
| Q1 24 | $68.5M | $147.2M |
自由现金流率GEOMEDP
| Q4 25 | -21.7% | 26.6% | ||
| Q3 25 | -2.1% | 35.7% | ||
| Q2 25 | 0.4% | 23.6% | ||
| Q1 25 | 6.7% | 20.7% | ||
| Q4 24 | -0.4% | 34.1% | ||
| Q3 24 | 15.0% | 26.0% | ||
| Q2 24 | 1.1% | 19.6% | ||
| Q1 24 | 11.3% | 28.8% |
资本支出强度GEOMEDP
| Q4 25 | 5.1% | 0.6% | ||
| Q3 25 | 13.7% | 1.6% | ||
| Q2 25 | 5.8% | 1.0% | ||
| Q1 25 | 5.1% | 1.8% | ||
| Q4 24 | 3.4% | 1.4% | ||
| Q3 24 | 3.1% | 2.0% | ||
| Q2 24 | 4.0% | 2.4% | ||
| Q1 24 | 2.4% | 1.1% |
现金转化率GEOMEDP
| Q4 25 | -3.69× | 1.43× | ||
| Q3 25 | 0.46× | 2.22× | ||
| Q2 25 | 1.35× | 1.65× | ||
| Q1 25 | 3.64× | 1.10× | ||
| Q4 24 | 1.19× | 1.63× | ||
| Q3 24 | 4.15× | 1.55× | ||
| Q2 24 | — | 1.32× | ||
| Q1 24 | 3.67× | 1.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEO
| Us Corrections And Detention | $498.0M | 70% |
| Electronic Monitoring And Supervision Services | $83.7M | 12% |
| Reentry Services | $72.2M | 10% |
| AU | $49.1M | 7% |
| ZA | $5.4M | 1% |
MEDP
| Metabolic | $249.8M | 35% |
| Oncology | $195.9M | 28% |
| Other | $88.3M | 12% |
| Central Nervous System | $73.2M | 10% |
| Cardiology | $63.0M | 9% |
| Antiviral And Anti Infective | $38.3M | 5% |
| Related Party | $10.3M | 1% |
